News-Medical.Net on MSN
Aptamer Group and Alphazyme execute licensing agreement for synthetic aptamer-based enzyme modulation in hot-start PCR
Aptamer Group plc, a developer of synthetic oligonucleotide-based binding reagents for life sciences applications, and ...
Amgen Inc. raises 2025 revenue guidance on strong Repatha and Imdelltra sales and dividend hike. Click for this AMGN update.
The U.S. Food and Drug Administration (FDA) on Wednesday approved Omeros Corporation (NASDAQ: OMER) Yartemlea ...
Mineralys (MLYS) is transitioning to a pre-commercial stage, supported by robust Phase 3 data and a strengthened cash ...
Morning Overview on MSN
This rare mutation wipes brain cells, and the trigger is finally known
A vanishingly rare genetic glitch in a single enzyme can erase a newborn’s brain cells in a matter of weeks, leaving doctors ...
Studies suggest berberine may influence glucose, lipid, and inflammatory pathways, though evidence quality varies and medical ...
Libtayo's approval for high-risk cutaneous squamous cell carcinoma offers a new immunotherapy option, targeting PD-1 ...
Through a recent notice, the Undergraduate Medical Education Board (UGMEB) of the National Medical Commission (NMC) has ...
The state’s affidavit noted that a similar odour issue at the Deonar dumping ground had improved after the constitution of an expert monitoring committee comprising senior officials and experts from ...
The achievements and discoveries in science and technology have not only profoundly reshaped how we live but also given us the confidence to confront challenges and embrace the future. Science and ...
Opioid receptors are a subset of G protein–coupled receptors (GPCRs). These membrane proteins transmit signals into the cell ...
Morning Overview on MSN
These new molecules make cells burn more calories with less effort
Drug developers are racing to design molecules that coax our cells into burning more energy even when we are sitting still, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results